Hanmi Pharm Co Ltd 2025 SR

The report highlights Hanmi Pharmaceutical's record-high revenues of KRW 1.5 trillion and its seventh consecutive year leading the domestic outpatient prescription market. The company advanced its 'h-Carbon Program' toward 2040 Net Zero, achieving a 23% reduction in water intake and a 60% reduction in waste treatment compared to 2018. Key achievements include maintaining the highest 'AAA' CP rating for five consecutive years and renewing ISO 27001 certification for the seventh year. Furthermore, the company expanded its R&D pipeline to 28 projects and secured 21 orphan drug designations, reinforcing its position as a global biopharmaceutical leader.

Company: Hanmi Pharm Co Ltd

Sector: Health Care

Country: South Korea

Year: 2025

Type: SR

Pages: 189

Back to company

Hanmi Pharm Co Ltd

Hanmi Pharm Co Ltd 2025 ESG Report

ESG Report

The report highlights Hanmi Pharmaceutical's record-high revenues of KRW 1.5 trillion and its seventh consecutive year leading the domestic outpatient prescription market. The company advanced its 'h-Carbon Program' toward 2040 Net Zero, achieving a 23% reduction in water intake and a 60% reduction in waste treatment compared to 2018. Key achievements include maintaining the highest 'AAA' CP rating for five consecutive years and renewing ISO 27001 certification for the seventh year. Furthermore, the company expanded its R&D pipeline to 28 projects and secured 21 orphan drug designations, reinforcing its position as a global biopharmaceutical leader.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2025

Reporting Period

Jan 1, 2024 - Dec 31, 2024

Fiscal Year

2024

Published

May 1, 2025

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Assurance

Assurance Provider

Assurance Standard

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Scope 3:

Energy Consumption

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Net Zero Target

Employees